Table 1. Clinical summary of hysterectomy donors.
Subject ID# | Age | Diagnosis resulting in hysterectomy | Menstrual cycle stage/Hormone therapy |
---|---|---|---|
For CCR5 and CD4 transcription | |||
5041 | 39 | Fibroids | Secretory/none |
5063 | 55 | Uterine bleeding | Unknown/none |
5082 | 40 | Prolapse | Secretory/none |
5165 | 52 | Menorraghia | Unknown/none |
5177 | 55 | Fibroids | Atrophic/none |
5210 | 62 | Prolapse | Atrophic/estrace cream* |
5995 | 48 | Pelvic Pain | Unknown/none |
For HIV-1 Reverse transcription | |||
5207 | 49 | Prolapse | Secretory/none |
5210 | 62 | Prolapse | Atrophic/estrace cream |
5233 | 44 | Fibroids | Inactive/Lupron depot* |
5254 | 52 | Fibroids | Unknown/none |
For IFN-transcription | |||
5805 | 67 | Prolapse | Atrophic/none |
5823 | 47 | Fibroids | Unknown/alesse-28* |
5879 | 59 | Prolapse | Unknown/none |
Estrace cream is a synthetic form of topically applied estrogen commonly used to treat vaginal atrophy; Lupron depot is a gonadotropin-releasing hormone sometimes used before hysterectomy in women with menorrhagia and anemia to prevent further bleeding prior to surgery; Alesse-28 is a synthetic progesterone and estradiol combination used as a contraceptive.